Charles River Laboratories International, Inc.
CRL
$291.76
$9.423.34%
NYSE
| 06/27/2026 | 03/28/2026 | 12/27/2025 | 09/27/2025 | 06/28/2025 | |
|---|---|---|---|---|---|
| Net Income | 90.02% | 94.63% | -608.17% | 4.01% | 105.45% |
| Total Depreciation and Amortization | -2.03% | -46.18% | 780.94% | -82.25% | 1.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.87% | -67.58% | 94.52% | 145.31% | -7.50% |
| Change in Net Operating Assets | 99.83% | -1,666.44% | 231.62% | -146.07% | 767.68% |
| Cash from Operations | 337.53% | -72.15% | -31.01% | 4.51% | 19.17% |
| Capital Expenditure | 44.36% | 37.15% | -150.00% | -0.80% | 40.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 84.63% | -- | -- | -- | -- |
| Divestitures | 93.80% | -- | -- | -- | -100.00% |
| Other Investing Activities | 170.91% | -82.19% | -304.72% | 192.31% | 43.24% |
| Cash from Investing | 106.89% | -339.45% | -175.42% | 9.76% | 17.90% |
| Total Debt Issued | -61.34% | 482.40% | 45.75% | -80.35% | 31.39% |
| Total Debt Repaid | -9.72% | -71.15% | 18.12% | 65.63% | -394.20% |
| Issuance of Common Stock | -67.54% | 72.01% | 35,450.00% | 100.00% | -- |
| Repurchase of Common Stock | 44.50% | -216,863.54% | -3.23% | 98.74% | 97.92% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -500.35% | -49.81% | 78.57% | 77.97% | -47.75% |
| Cash from Financing | -147.35% | 770.45% | 66.02% | 32.74% | -115.45% |
| Foreign Exchange rate Adjustments | -162.58% | -68.23% | 229.47% | -123.95% | 140.63% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 338.14% | -362.59% | -72.32% | 152.10% | -279.63% |